Evidence map›Paper›PMID 31062017›Full record

ArticleNucleic acids research2019

Targeted amplification of a sequence of interest in artificial chromosome in mammalian cells.

Manami Asoshina, Genki Myo, Natsuko Tada, Koji Tajino, Noriaki Shimizu

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Manami AsoshinaGraduate School of Biosphere Science, Hiroshima University, Higashi-hiroshima, Hiroshima 739-8521, Japan.
Genki MyoGraduate School of Biosphere Science, Hiroshima University, Higashi-hiroshima, Hiroshima 739-8521, Japan.
Natsuko TadaChromocenter Inc., Yonago, Tottori 683-0823, Japan.
Koji TajinoChromocenter Inc., Yonago, Tottori 683-0823, Japan.
Noriaki ShimizuGraduate School of Biosphere Science, Hiroshima University, Higashi-hiroshima, Hiroshima 739-8521, Japan.
Hiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A plasmid with a replication initiation region (IR) and a matrix attachment region (MAR) initiates gene amplification in mammalian cells at a random chromosomal location. A mouse artificial chromosome (MAC) vector can stably carry a large genomic region. In this study we combined these two technologies with the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated nuclease (Cas)9 strategy to achieve targeted amplification of a sequence of interest. We previously showed that the IR/MAR plasmid was amplified up to the extrachromosomal tandem repeat; here we demonstrate that cleavage of these tandem plasmids and MAC by Cas9 facilitates homologous recombination between them. The plasmid array on the MAC could be further extended to form a ladder structure with high gene expression by a breakage-fusion-bridge cycle involving breakage at mouse major satellites. Amplification of genes on the MAC has the advantage that the MAC can be transferred between cells. We visualized the MAC in live cells by amplifying the lactose operator array on the MAC in cells expressing lactose repressor-green fluorescent protein fusion protein. This targeted amplification strategy is in theory be applicable to any sequence at any chromosomal site, and provides a novel tool for animal cell technology.

Indexed as

DNA ReplicationMatrix Attachment RegionsReplication OriginAnimalsCHO CellsChromosomes, ArtificialClustered Regularly Interspaced Short Palindromic RepeatsCricetinaeCricetulusCRISPR-Cas SystemsEndonucleasesGene AmplificationHomologous RecombinationMicePlasmidsEndonucleases

Identifiers

PMID31062017
PMCPMC6582328
OpenAlexW2944226924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.